<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00484354</url>
  </required_header>
  <id_info>
    <org_study_id>IRB00002409</org_study_id>
    <nct_id>NCT00484354</nct_id>
  </id_info>
  <brief_title>Use of Bicarbonate to Reduce the Incidence of Acute Renal Failure After Cardiac Surgery</brief_title>
  <official_title>Reduction of Acute Renal Failure Associated With Cardiovascular Surgery: A Randomized Study Comparing Sodium Bicarbonate to Normal Saline</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Wake Forest University Health Sciences</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Wake Forest University Health Sciences</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine if the incidence of acute renal failure (ARF) in&#xD;
      high risk patients who undergo coronary artery bypass grafting (CABG) is reduced by treating&#xD;
      patients in the perioperative period with intravenous (IV) sodium bicarbonate. Patients will&#xD;
      be randomized in a 50:50 allocation to receive either IV sodium bicarbonate or IV normal&#xD;
      saline. The volume of fluid given in each arm of the study is equal. All other interventions&#xD;
      in those patients will be according to standard cardiothoracic anesthesia protocol at our&#xD;
      institution.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a randomized, controlled, single center study in patients felt to be at high risk for&#xD;
      ARF following CABG surgery. Patients who have met the selection criteria noted below will be&#xD;
      randomized to one of two treatment arms:&#xD;
&#xD;
      I) Patients allocated to the sodium bicarbonate (NaHCO3) arm will receive a 0.150 M NaHCO3&#xD;
      solution prepared in a sterile water base. An initial bolus of 0.150 M NaHCO3 at 5.0 ml/kg&#xD;
      will be given over fifteen minutes prior to surgery. Following the bolus, the 0.150 M NaHCO3&#xD;
      infusion will be run at 1.0 ml/kg/hr during the procedure and for six (6) hours afterwards.&#xD;
      The NaHCO3 infusion will then be decreased to 0.4 ml/kg/hr for a further twelve (12) hours.&#xD;
      The goal in the NaHCO3 arm is to provide a total dose of approximately 2.5-3.0 mEq/kg of&#xD;
      sodium bicarbonate. This dose was determined from prior studies and found to lead to a slight&#xD;
      increase in the serum bicarbonate level post-operatively. Anecdotally, the metabolic stress&#xD;
      of CABG surgery often leads to a decline in the serum bicarbonate level in patients not&#xD;
      treated with alkali therapy.&#xD;
&#xD;
      II) Patients allocated to the normal saline (NS) arm will receive an initial bolus consisting&#xD;
      of 0.154 M NaCl (NS) at 5.0 ml/kg given over fifteen minutes prior to surgery. Following the&#xD;
      bolus, these patients will receive NS (0.154 M) at a rate of 1.0 ml/kg/hour during the&#xD;
      procedure and for six (6) hours afterwards. The rate will then be decreased to 0.4 ml/kg/hour&#xD;
      for a further twelve (12) hours as done in the NaHCO3 treatment arm above. There will be a&#xD;
      maximum rate of infusion of 125 mL/min used in both study arms to avoid volume overload&#xD;
      issues in morbidly obese patients.&#xD;
&#xD;
      There will be no other deviation from standard protocol when treating these patients&#xD;
      undergoing CABG at our institution. The standard protocol is dictated by both the&#xD;
      cardiothoracic surgeons and anesthesiologists involved with each individual case. The purpose&#xD;
      of this study is to compare the incidence of ARF (maximal change in SCr) in high risk&#xD;
      patients undergoing CABG when treated with either a NS or NaHCO3 maintenance infusion. This&#xD;
      study will test the hypothesis that treatment with NaHCO3 may have a protective effect over&#xD;
      NS in preventing AFR following CABG in a high risk population.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>May 2006</start_date>
  <completion_date type="Actual">December 2013</completion_date>
  <primary_completion_date type="Actual">December 2011</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of Participants Who Developed Acute Kidney Injury Within 72 Hours</measure>
    <time_frame>72 hours post-operative</time_frame>
    <description>Number (percentage) of patients who developed acute kidney injury within 72 hours, defined by an increase in serum creatinine level of 0.3 mg/dl from baseline</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in GFR Over 72 Hours Post Operatively</measure>
    <time_frame>72 hours</time_frame>
    <description>25% or greater change in serum creatinine level</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of Hospital Stay</measure>
    <time_frame>Until hospital discharge, up to 30 days</time_frame>
    <description>Length of hospital stay in days</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants With Need for Dialysis</measure>
    <time_frame>Until hospital discharge, up to 30 days</time_frame>
    <description>Number of participants needing dialysis</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mortality</measure>
    <time_frame>Until hospital discharge, up to 30 days</time_frame>
    <description>Number of patients who died during the hospitalization</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">123</enrollment>
  <condition>Kidney Failure, Acute</condition>
  <condition>Renal Replacement Therapy</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Bicarbonate administration</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Normal saline administration</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Sodium bicarbonate</intervention_name>
    <description>IV bicarbonate given with amount based on patient weight</description>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Normal saline</intervention_name>
    <description>IV Normal saline with volume given determined by patient weight</description>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Bicarbonate</intervention_name>
    <description>IV bicarbonate, dosed by weight</description>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Normal saline, with volume given based on patient weight</description>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Calculated GFR ≤ 60 ml/min/m2 (MDRD)&#xD;
&#xD;
        OR&#xD;
&#xD;
          -  Any combination of two (2) of the following:&#xD;
&#xD;
          -  Age ≥ 70&#xD;
&#xD;
          -  Complex surgery (any of the following):&#xD;
&#xD;
               -  CABG/Valve&#xD;
&#xD;
               -  Redo operation&#xD;
&#xD;
               -  Deep hypothermic arrest&#xD;
&#xD;
          -  ≥ 2 valves&#xD;
&#xD;
          -  History of PVD surgery&#xD;
&#xD;
          -  EF &lt; 35%&#xD;
&#xD;
          -  Presence of diabetes mellitus&#xD;
&#xD;
          -  Prior kidney transplant&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Age &lt; 18&#xD;
&#xD;
          -  Pre-existing ESRD (dialysis patients)&#xD;
&#xD;
          -  Pre-op GFR ≤ 15 ml/min/m2&#xD;
&#xD;
          -  Pre-op bicarbonate level ≥ 30 mEq/L&#xD;
&#xD;
          -  Emergency surgery (unable to effectively consent)&#xD;
&#xD;
          -  Pregnancy&#xD;
&#xD;
          -  Heart transplant (OHT)&#xD;
&#xD;
          -  Aortic surgery (proximal or distal)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Michael V. Rocco, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Wake Forest University School of Medicine, Dept of Internal Medicine, Division of Nephrology</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Wake Forest University School of Medicine</name>
      <address>
        <city>Winston-Salem</city>
        <state>North Carolina</state>
        <zip>27157</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2018</verification_date>
  <study_first_submitted>June 6, 2007</study_first_submitted>
  <study_first_submitted_qc>June 7, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 8, 2007</study_first_posted>
  <results_first_submitted>August 22, 2018</results_first_submitted>
  <results_first_submitted_qc>September 20, 2018</results_first_submitted_qc>
  <results_first_posted type="Actual">October 16, 2018</results_first_posted>
  <last_update_submitted>September 20, 2018</last_update_submitted>
  <last_update_submitted_qc>September 20, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">October 16, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Acute Renal Failure</keyword>
  <keyword>Cardiac Surgery</keyword>
  <keyword>Sodium Bicarbonate</keyword>
  <keyword>Length of Stay</keyword>
  <keyword>Mortality</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Renal Insufficiency</mesh_term>
    <mesh_term>Acute Kidney Injury</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>IV Sodium Bicarbonate</title>
          <description>IV sodium bicarbonate given with amount based on patient weight</description>
        </group>
        <group group_id="P2">
          <title>IV Normal Saline</title>
          <description>IV Normal saline with volume given determined by patient weight</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="64"/>
                <participants group_id="P2" count="59"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="63"/>
                <participants group_id="P2" count="57"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="2"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>IV Sodium Bicarbonate</title>
          <description>IV sodium bicarbonate given with amount based on patient weight</description>
        </group>
        <group group_id="B2">
          <title>IV Normal Saline</title>
          <description>IV Normal saline with volume given determined by patient weight</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="64"/>
            <count group_id="B2" value="59"/>
            <count group_id="B3" value="123"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="70.2" spread="12.6"/>
                    <measurement group_id="B2" value="69.7" spread="13.5"/>
                    <measurement group_id="B3" value="70" spread="13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="30"/>
                    <measurement group_id="B2" value="16"/>
                    <measurement group_id="B3" value="46"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="34"/>
                    <measurement group_id="B2" value="43"/>
                    <measurement group_id="B3" value="77"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                    <measurement group_id="B2" value="9"/>
                    <measurement group_id="B3" value="14"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="57"/>
                    <measurement group_id="B2" value="47"/>
                    <measurement group_id="B3" value="104"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="64"/>
                    <measurement group_id="B2" value="59"/>
                    <measurement group_id="B3" value="123"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Number of Participants Who Developed Acute Kidney Injury Within 72 Hours</title>
        <description>Number (percentage) of patients who developed acute kidney injury within 72 hours, defined by an increase in serum creatinine level of 0.3 mg/dl from baseline</description>
        <time_frame>72 hours post-operative</time_frame>
        <group_list>
          <group group_id="O1">
            <title>IV Sodium Bicarbonate</title>
            <description>IV sodium bicarbonate given with amount based on patient weight</description>
          </group>
          <group group_id="O2">
            <title>IV Normal Saline</title>
            <description>IV Normal saline with volume given determined by patient weight</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants Who Developed Acute Kidney Injury Within 72 Hours</title>
          <description>Number (percentage) of patients who developed acute kidney injury within 72 hours, defined by an increase in serum creatinine level of 0.3 mg/dl from baseline</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="63"/>
                <count group_id="O2" value="57"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="17"/>
                    <measurement group_id="O2" value="14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in GFR Over 72 Hours Post Operatively</title>
        <description>25% or greater change in serum creatinine level</description>
        <time_frame>72 hours</time_frame>
        <group_list>
          <group group_id="O1">
            <title>IV Sodium Bicarbonate</title>
            <description>IV sodium bicarbonate given with amount based on patient weight</description>
          </group>
          <group group_id="O2">
            <title>IV Normal Saline</title>
            <description>IV Normal saline with volume given determined by patient weight</description>
          </group>
        </group_list>
        <measure>
          <title>Change in GFR Over 72 Hours Post Operatively</title>
          <description>25% or greater change in serum creatinine level</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="63"/>
                <count group_id="O2" value="57"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="21"/>
                    <measurement group_id="O2" value="21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Length of Hospital Stay</title>
        <description>Length of hospital stay in days</description>
        <time_frame>Until hospital discharge, up to 30 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>IV Sodium Bicarbonate</title>
            <description>IV sodium bicarbonate given with amount based on patient weight</description>
          </group>
          <group group_id="O2">
            <title>IV Normal Saline</title>
            <description>IV Normal saline with volume given determined by patient weight</description>
          </group>
        </group_list>
        <measure>
          <title>Length of Hospital Stay</title>
          <description>Length of hospital stay in days</description>
          <units>days</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="63"/>
                <count group_id="O2" value="57"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="14.2" spread="15.4"/>
                    <measurement group_id="O2" value="14.6" spread="14.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants With Need for Dialysis</title>
        <description>Number of participants needing dialysis</description>
        <time_frame>Until hospital discharge, up to 30 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>IV Sodium Bicarbonate</title>
            <description>IV sodium bicarbonate given with amount based on patient weight</description>
          </group>
          <group group_id="O2">
            <title>IV Normal Saline</title>
            <description>IV Normal saline with volume given determined by patient weight</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Need for Dialysis</title>
          <description>Number of participants needing dialysis</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="63"/>
                <count group_id="O2" value="57"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4"/>
                    <measurement group_id="O2" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Mortality</title>
        <description>Number of patients who died during the hospitalization</description>
        <time_frame>Until hospital discharge, up to 30 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>IV Sodium Bicarbonate</title>
            <description>IV sodium bicarbonate given with amount based on patient weight</description>
          </group>
          <group group_id="O2">
            <title>IV Normal Saline</title>
            <description>IV Normal saline with volume given determined by patient weight</description>
          </group>
        </group_list>
        <measure>
          <title>Mortality</title>
          <description>Number of patients who died during the hospitalization</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="63"/>
                <count group_id="O2" value="57"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9"/>
                    <measurement group_id="O2" value="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Until hospital discharge, up to 30 days</time_frame>
      <group_list>
        <group group_id="E1">
          <title>IV Sodium Bicarbonate</title>
          <description>IV sodium bicarbonate given with amount based on patient weight</description>
        </group>
        <group group_id="E2">
          <title>IV Normal Saline</title>
          <description>IV Normal saline with volume given determined by patient weight</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="9" subjects_at_risk="63"/>
                <counts group_id="E2" subjects_affected="10" subjects_at_risk="57"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="9" subjects_at_risk="63"/>
                <counts group_id="E2" subjects_affected="10" subjects_at_risk="57"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Mortality</sub_title>
                <description>Mortality</description>
                <counts group_id="E1" events="9" subjects_affected="9" subjects_at_risk="63"/>
                <counts group_id="E2" events="10" subjects_affected="10" subjects_at_risk="57"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="63"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="57"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>Dialysis</sub_title>
                <description>Need for dialysis for treatment of acute kidney injury</description>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="63"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="57"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Michael Rocco, MD</name_or_title>
      <organization>Wake Forest School of Medicine</organization>
      <phone>3367164650</phone>
      <email>mrocco@wakehealth.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

